Cargando…
Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models
Transforming growth factor (TGF)-βs are plausible candidate tumor suppressors in the breast. They also have oncogenic activities under certain circumstances, however. Genetically altered mouse models provide powerful tools to analyze the complexities of TGF-βaction in the context of the whole animal...
Autores principales: | Wakefield, Lalage M, Yang, Yu-an, Dukhanina, Oksana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139431/ https://www.ncbi.nlm.nih.gov/pubmed/11250699 http://dx.doi.org/10.1186/bcr41 |
Ejemplares similares
-
Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003) -
Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
por: Zujewski, JoAnne, et al.
Publicado: (2001) -
Disruption of Transforming Growth Factor β Signaling by a Novel Ligand-dependent Mechanism
por: Fernandez, Tania, et al.
Publicado: (2002) -
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer
por: Sato, Misako, et al.
Publicado: (2014) -
Brightfield Proximity Ligation Assay Reveals Both Canonical and Mixed Transforming Growth Factor-β/Bone Morphogenetic Protein Smad Signaling Complexes in Tissue Sections
por: Flanders, Kathleen C., et al.
Publicado: (2014)